Trial Profile

Phase 1b clinical study of OPM-201 for people with Parkinson's disease.

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 01 Apr 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Apr 2026 New trial record
03 Mar 2026 The According to Oncodesign media release, current grant supports the CMC work related to the preparation of Drug Product (drug tablets to be used in the studies) for the Phase 1b and the start of Phase 2 studies, starting from the available 67 kgs of GMP Drug Substance (the pure OPM-201 chemical material).
03 Mar 2026 The According to Oncodesign media release, total duration of the grant program is 24 months, with the preparation of the Phase 1b drug tablets scheduled to finish early 2027

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com